Navigation Links
Hypertronics HyperGrip(R) and D Series Connectors Selected for SynCardia's Total Artificial Heart

HUDSON, Mass., Aug. 10 /PRNewswire/ -- Hypertronics Corporation, a Smiths Interconnect business and world-leading provider of high performance interconnect solutions for the most demanding applications; today announced that its HyperGrip and D series circular connectors were selected by SynCardia Systems, Inc. ( to provide critical interconnect reliability for their Freedom(TM) driver, which is currently under development and designed to power the CardioWest(TM) temporary Total Artificial Heart.

(Photo: )

The Hypertronics HyperGrip and D series connectors were chosen because of their reliable electromechanical performance characteristics: high cycle life, low contact resistance, low insertion/extraction force and resistance to shock and vibration.

The CardioWest(TM) temporary Total Artificial Heart manufactured by SynCardia is the only FDA and CE approved temporary Total Artificial Heart in the world. In the pivotal clinical study of the CardioWest artificial heart, 79% of patients receiving the artificial heart survived to transplant. This is the highest bridge-to-transplant rate for any medical device. The artificial heart has been implanted in more than 780 patients, accounting for more than 150 patient years of life on the device. The Freedom(TM) driver is designed to allow patients to be discharged from the hospital while they wait for a donor heart transplant which eliminates most in-hospital costs for this portion of their care. It is designed to improve their quality of life and weigh less than 10 lbs.

"For the artificial heart and driver, ultra reliable connectivity is paramount, so we chose the technology that could deliver," said Rodger Ford, SynCardia President and CEO. "Hypertronics contacts have the proven Hypertac technology that eliminates the uncertainty about connectivity."

Since 2004, Hypertronics has maintained ISO13485:2003 certification to ensure the quality management systems are in compliance with the medical device standards for the design and manufacture of components used in medical devices.

"Hypertronics is unwavering in its commitment to providing the medical device market with reliable products that are leading edge," comments Vadim Radunsky, Hypertronics President. "We are excited to partner with SynCardia."

HyperGrip is designed to meet medical industry requirements such as finger-proofing to IEC60601, flammability rating to UL94 V0, and compatibility with most sterilization requirements. A user-configurable circular connector, HyperGrip is color-coded and customer-keyable for accurate and quick connections on medical equipment.

About the Hypertac Technology

Hypertronics Hypertac(R) advanced wire basket socket contact system is distinguished by its unique design. The shape of the contact sleeve is formed by wires strung at an angle to the socket axis. When the pin is inserted into this sleeve, the wires stretch around it, providing a number of linear contact paths, therefore extending the contact area around the pin to 360 degrees. The low mass and resulting low inertia of the wires enable them to withstand the most abrupt or extreme excursions of the pin without loss of contact -- a critical factor for ensuring electrical integrity in harsh environments and demanding applications.

SOURCE Hypertronics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hypertronics Introduces ImplanTac(TM) for IS-1 and draft IS-4 Form Factors
2. MyMedLab Releases First Offer in Its Unique Personalized Medicine Series
3. 14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series Kicks-Off in New York City
4. American Health Assistance Foundation & Asbury Methodist Village to Host Special Community Screening and Discussion of the HBO Series, The Alzheimers Project
5. New Custom Hybrid Planetary Gearbox Series from NMB
6. Ohio Man Top Bidder for Preakness Winners Halter, First of Five Items in Horses Season-Long Auction Series
7. Sharing Miracles Television Program to Feature Four-Time World Series Champ Darryl Strawberry
8. Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery
9. Launches Healthy Living Series
10. Novasys Medical Receives $18.95 Million in Second Tranche of Series D Financing
11. MTVs Season Finale of 16 & Pregnant Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The ... the important role that meat and poultry play in a healthy, balanced diet. ... nutrition quiz where visitors can check their “meat IQ,” a section offering straight ...
(Date:12/1/2015)... ... 01, 2015 , ... Integrated Rental Services (“Integrated Rental”), a ... LLC (“JII”). , With support from JII, Integrated Rental is poised for expansion ... centers, clinics, research labs and medical facilities across the United States. , General ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one ... its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design ... announced that it has been selected as a 2015 U.S.A. Taste Champion in the ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... the 1980s we have seen vast improvements in scientific research and discoveries, leading ... strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric breast ... focus of numerous abstracts accepted for presentation here, at the 101st Annual Radiology ... highlight the use of Volpara Solutions’ quantitative breast imaging software tools for providing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 01, 2015 ... the "Veterinary Equipment and Disposables Market by ... report to their offering. --> ... "Veterinary Equipment and Disposables Market by product, ... report to their offering. --> Research ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), ... commercialization of therapies for cardiovascular conditions via the inhalation ... business in Australia . InCarda is ... Australia in the first half ... and medical centers in Adelaide ...
Breaking Medicine Technology: